Skip to main content
. 2021 Aug 28;41(2):148–157. doi: 10.1016/j.healun.2021.08.010

Figure 1.

Figure 1

Quantitation of receptor-binding domain (RBD) IgG (A) and neutralizing (B) antibodies before and after a third, booster, BNT162b2 dose. Solid lines and numbers indicate the geometric mean titer. In each panel, the horizontal bars indicate the mean geometric titers and the I bars indicate 95% confidence intervals. Dashed line indicates the limit level of positive antibodies.